Safety and efficacy of daratumumab-based regimens in elderly (≥75 y) patients (Pts) with relapsed or refractory multiple myeloma (RRMM): Subgroup analysis of POLLUX and CASTOR.

被引：2
|
作者：
Mateos, Maria-Victoria
Spencer, Andrew
Nooka, Ajay K.
Pour, Ludek
Weisel, Katja C.
Cavo, Michele
Laubach, Jacob
Cook, Gordon
Iida, Shinsuke
Benboubker, Lotfi
Usmani, Saad Zafar
Yoon, Sung-Soo
Bahlis, Nizar J.
Chiu, Christopher
Schecter, Jordan Mark
Wu, Kaida
Qin, Xiang
Soong, David
Dimopoulos, Meletios A.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.8033
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8033
引用
收藏
页数：5
相关论文
共 50 条
  • [21] Comparison of daratumumab-based regimens as second-line therapy in relapsed/ refractory multiple myeloma
    Charalampous, Charalampos
    Goel, Utkarsh
    Kapoor, Prashant
    Binder, Moritz
    Buadi, Francis
    Dingli, David
    Dispenzieri, Angela
    Fonder, Amie L.
    Gertz, Morie A.
    Gonsalves, Wilson I.
    Hayman, Suzanne R.
    Hobbs, Miriam A.
    Hwa, Yi Lisa
    Kourelis, Taxiarchis
    Lacy, Martha
    Leung, Nelson
    Lin, Yi
    Warsame, Rahma M.
    Rajkumar, S. Vincent
    Kumar, Shaji
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [22] Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma
    Charalampous, Charalampos
    Goel, Utkarsh
    Kapoor, Prashant
    Binder, Moritz
    Buadi, Francis K.
    Cook, Joselle
    Dingli, David
    Dispenzieri, Angela
    Fonder, Amie L.
    Gertz, Morie A.
    Gonsalves, Wilson
    Hayman, Suzanne R.
    Hobbs, Miriam A.
    Hwa, Yi L.
    Kourelis, Taxiarchis
    Lacy, Martha Q.
    Leung, Nelson
    Lin, Yi
    Warsame, Rahma
    Kyle, Robert A.
    Rajkumar, S. Vincent
    Kumar, Shaji K.
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [23] Comparison of daratumumab-based regimens as second-line therapy in relapsed/refractory multiple myeloma
    Charalampos Charalampous
    Utkarsh Goel
    Prashant Kapoor
    Moritz Binder
    Francis K. Buadi
    Joselle Cook
    David Dingli
    Angela Dispenzieri
    Amie L. Fonder
    Morie A. Gertz
    Wilson Gonsalves
    Suzanne R. Hayman
    Miriam A. Hobbs
    Yi L. Hwa
    Taxiarchis Kourelis
    Martha Q. Lacy
    Nelson Leung
    Yi Lin
    Rahma Warsame
    Robert A. Kyle
    S. Vincent Rajkumar
    Shaji K. Kumar
    Blood Cancer Journal, 13
  • [24] EFFICACY AND SAFETY OF DARATUMUMAB, BORTEZOMIB AND DEXAMETHASONE (DVD) VERSUS BORTEZOMIB AND DEXAMETHASONE (VD) IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM): UPDATED ANALYSIS OF CASTOR
    Weisel, K.
    Lentzsch, S.
    Mateos, M. V.
    Hungria, V.
    Munder, M.
    Nooka, A.
    Mark, T.
    Quach, H.
    Scott, E. C.
    Lee, J. -J.
    Sonneveld, P.
    Casneuf, T.
    Chiu, C.
    Qin, X.
    Amin, H.
    Thiyagarajah, P.
    Schecter, J. M.
    Qi, M.
    Spencer, A.
    HAEMATOLOGICA, 2017, 102 : 168 - 169
  • [25] Daratumumab, Bortezomib, and Dexamethasone (DVd) Versus Bortezomib and Dexamethasone (Vd) in Relapsed or Refractory Multiple Myeloma (RRMM): Updated Efficacy and Safety Analysis of Castor
    Spencer, Andrew
    Hungria, Vania T. M.
    Mateos, Maria-Victoria
    Nooka, Ajay
    Estell, Jane
    Barreto, Wolney G.
    Corradini, Paolo
    Min, Chang-Ki
    Medvedova, Eva
    Thiyagarajah, Piruntha
    Deraedt, William
    Chiu, Christopher
    Schecter, Jordan
    Weisel, Katja C.
    BLOOD, 2017, 130
  • [26] UPDATED EFFICACY AND SAFETY ANALYSIS OF DARATUMUMAB, BORTEZOMIB, AND DEXAMETHASONE (DVD) VERSUS BORTEZOMIB AND DEXAMETHASONE (VD) FOR RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM; CASTOR)
    Mateos, M. M.
    Spencer, A.
    Hungria, V
    Nooka, A. K.
    Estell, J.
    Barreto, W.
    Corradini, P.
    Min, C. K.
    Medvedova, E.
    Thiyagarajah, P.
    Deraedt, W.
    Chiu, C.
    Schecter, J. M.
    Weisel, K.
    HAEMATOLOGICA, 2018, 103 : 30 - 30
  • [27] Daratumumab, bortezomib and dexamethasone (DVd) vs bortezomib and dexamethasone (Vd) in relapsed or refractory multiple myeloma (RRMM): Efficacy and safety update (CASTOR).
    Lentzsch, Suzanne
    Weisel, Katja C.
    Mateos, Maria-Victoria
    Hungria, Vania
    Munder, Markus
    Nooka, Ajay K.
    Mark, Tomer
    Quach, Hang
    Scott, Emma Catherine
    Lee, Je-Jung
    Sonneveld, Pieter
    Casneuf, Tineke
    Chiu, Christopher
    Qin, Xiang
    Amin, Himal
    Thiyagarajah, Piruntha
    Schecter, Jordan Mark
    Qi, Ming
    Spencer, Andrew
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [28] Efficacy of daratumumab-based therapies in patients with relapsed, refractory multiple myeloma treated outside of clinical trials
    Lakshman, Arjun
    Abeykoon, Jithma P.
    Kumar, Shaji K.
    Rajkumar, S. Vincent
    Dingli, David
    Buadi, Francis K.
    Gonsalves, Wilson I.
    Leung, Nelson
    Dispenzieri, Angela
    Kourelis, Taxiarchis V.
    Go, Ronald S.
    Lacy, Martha Q.
    Hobbs, Miriam A.
    Lin, Yi
    Warsame, Rahma
    Lust, John
    Fonder, Amie L.
    Hwa, Yi L.
    Hayman, Suzanne R.
    Russell, Stephen J.
    Kyle, Robert A.
    Gertz, Morie A.
    Kapoor, Prashant
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (11) : 1146 - 1155
  • [29] EFFICACY AND SAFETY OF DARATUMUMAB, LENALIDOMIDE, AND DEXAMETHASONE VERSUS RD ALONE IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: UPDATED ANALYSIS OF POLLUX
    Dimopoulos, M. A.
    Moreau, P.
    Nahi, H.
    Plesner, T.
    Goldschmidt, H.
    Suzuki, K.
    Orlowski, R. Z.
    Rabin, N.
    Leiba, M.
    Oriol, A.
    Chari, A.
    San-Miguel, J.
    Richardson, P. G.
    Usmani, S. Z.
    O'Rourke, L.
    Wu, K.
    Casneuf, T.
    Chiu, C.
    Qin, X.
    Bahlis, N. J.
    HAEMATOLOGICA, 2017, 102 : 108 - 109
  • [30] Daratumumab (DARA) plus bortezomib and dexamethasone (D-Vd) or lenalidomide and dexamethasone (D-Rd) in relapsed or refractory multiple myeloma (RRMM): subgroup analyses of CASTOR and POLLUX
    Mateos, Maria-Victoria
    Richardson, Paul
    Weisel, Katja
    Moreau, Philippe
    San-Miguel, Jesus
    Goldschmidt, Hartmut
    Orlowski, Robert
    Sonneveld, Pieter
    Reece, Donna E.
    Suzuki, Kenshi
    Bahlis, Nizar
    Yoon, Sung-Soo
    Spencer, Andrew
    Nooka, Ajay
    Hungria, Vania
    Plesner, Torben
    Ben Yehuda, Dina
    Pei, Huiling
    Mayo, Wendy Garvin
    Gai, Xue
    Carey, Jodi
    Carson, Robin
    Dimopoulos, Meletios A.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S179 - S180
12345